The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
A grey start to the weekend with patchy rain for Scotland and eastern England.
A 31-year-old, stabbed nine times when he asked a man to stop harassing his girlfriend, has raised more than $28,000 for hospital treatment.
The Prince has called for "zero tolerance" on the ivory trade, which he says is increasing "alarmingly".